IRIS
BORGIA, GUGLIELMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.317
NA - Nord America 7.661
EU - Europa 5.270
SA - Sud America 883
AF - Africa 223
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.261
SG - Singapore 3.763
RU - Federazione Russa 2.666
VN - Vietnam 1.676
CN - Cina 1.477
IT - Italia 752
BR - Brasile 715
HK - Hong Kong 628
NL - Olanda 316
DE - Germania 272
FI - Finlandia 265
FR - Francia 259
CA - Canada 248
IE - Irlanda 176
GB - Regno Unito 159
JP - Giappone 145
IN - India 123
UA - Ucraina 123
MX - Messico 95
BD - Bangladesh 84
AR - Argentina 73
SE - Svezia 71
ZA - Sudafrica 69
PL - Polonia 56
IQ - Iraq 52
CI - Costa d'Avorio 49
TH - Thailandia 46
TR - Turchia 40
TW - Taiwan 38
ES - Italia 36
KR - Corea 36
PH - Filippine 36
PK - Pakistan 24
AT - Austria 23
LT - Lituania 23
EC - Ecuador 21
UZ - Uzbekistan 21
ID - Indonesia 20
TN - Tunisia 18
VE - Venezuela 18
EG - Egitto 16
JO - Giordania 15
MA - Marocco 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 11
KE - Kenya 11
SA - Arabia Saudita 11
CL - Cile 10
CO - Colombia 9
NP - Nepal 9
SV - El Salvador 9
UY - Uruguay 9
AZ - Azerbaigian 8
BO - Bolivia 8
BE - Belgio 7
JM - Giamaica 7
RS - Serbia 7
DZ - Algeria 6
KZ - Kazakistan 6
SN - Senegal 6
AF - Afghanistan, Repubblica islamica di 5
AO - Angola 5
BG - Bulgaria 5
CR - Costa Rica 5
GT - Guatemala 5
IR - Iran 5
QA - Qatar 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
MN - Mongolia 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
BW - Botswana 3
EU - Europa 3
GP - Guadalupe 3
LU - Lussemburgo 3
LV - Lettonia 3
NI - Nicaragua 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
CU - Cuba 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HT - Haiti 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 22.305
Salva come PNG Salva come JPEG
Città #
Singapore 1.800
San Jose 1.246
Chandler 606
Hong Kong 597
Moscow 586
Ashburn 560
Ho Chi Minh City 486
Beijing 434
Hanoi 420
Santa Clara 348
Amsterdam 292
Millbury 282
The Dalles 237
Los Angeles 234
Princeton 198
Lauterbourg 190
Nanjing 189
Naples 177
New York 145
Ottawa 139
Tokyo 130
Jacksonville 118
Boston 105
Napoli 104
Munich 94
Des Moines 87
Hefei 84
São Paulo 83
Buffalo 74
Da Nang 74
Redondo Beach 73
Wilmington 71
Nanchang 64
Dallas 56
Haiphong 55
Warsaw 52
Boardman 51
Orem 50
Brooklyn 48
Houston 47
Chicago 44
Mexico City 43
Montreal 42
Seattle 41
Turku 41
Hebei 40
Denver 39
Jiaxing 38
Atlanta 37
Chennai 37
Frankfurt am Main 37
Helsinki 35
Poplar 34
Shenyang 34
Ann Arbor 33
Johannesburg 31
Nuremberg 31
Tianjin 31
Woodbridge 31
San Francisco 30
Lawrence 28
Stockholm 28
London 26
Phoenix 25
Hải Dương 23
Biên Hòa 22
Changsha 22
Ninh Bình 22
Toronto 22
Norwalk 21
Falkenstein 19
Milan 19
Querétaro 19
Nha Trang 18
Tashkent 18
Baghdad 17
Tân Tiến 17
Belo Horizonte 16
Can Tho 16
Council Bluffs 16
Ankara 15
Porto Alegre 15
Bến Tre 14
Dhaka 14
Dublin 14
Indiana 14
Manchester 14
Rio de Janeiro 14
Rome 14
Shanghai 14
Thái Nguyên 14
Salvador 13
Bangkok 12
Florence 12
Seoul 12
Amman 11
Calgary 11
Curitiba 11
Falls Church 11
Guangzhou 11
Totale 12.089
Salva come PNG Salva come JPEG
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 190
Febbre di origine sconosciuta (FUO): nostra casistica 177
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 173
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 170
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 168
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 161
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 158
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 155
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 153
Asunaprevir for hepatitis C: A safety evaluation 152
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 151
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 149
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 148
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 148
HIV and hepatitis C virus: facts and controversies 147
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 147
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 146
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 145
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 144
Does compulsory vaccination limit personal freedom? Ethical issues 144
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 142
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 141
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 141
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 141
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 139
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 138
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 137
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 137
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 137
Human immunodeficiency virus per se exerts atherogenic effects. 135
Beclabuvir for the treatment of hepatitis C 135
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 132
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 132
[Intranuclear particles in chronic non-A, non-B hepatitis: what diagnostic significance?]. 131
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 131
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 130
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 130
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 129
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 129
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 128
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 128
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 127
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 127
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 126
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 126
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 126
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 126
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 126
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 125
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 125
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 125
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 125
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 125
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 124
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 124
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 123
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 122
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE 121
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 120
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 120
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 120
Is anticoagulation with novel oral anticoagulants an effective treatment for tuberculosis patients not achieving a therapeutic range with vitamin k antagonists? A Systematic Review 120
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 119
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 118
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 118
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 117
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 117
Current evidence on the management of hepatitis B in pregnancy 116
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 116
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 116
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 115
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 115
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 115
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma 115
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review 115
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 115
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 114
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. 114
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 113
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis 113
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 113
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 112
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 112
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 112
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 111
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 110
POEMS syndrome: clinical, pathological and immunological study of a case 110
Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients. 108
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 108
Compromissione cognitiva subclinica in pazienti HCV-positivi 107
Secondary hemosiderosis, iron depletion and hepatitis C viral load 107
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 107
Diffusione dell'infezione da virus epatitico B in ambiente odontoiatrico 106
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]. 106
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 106
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 106
Specific immunoglobulin against HCV: new perspectives. 105
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. 105
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 105
Tenofovir and its potential in the treatment of hepatitis B virus 104
Totale 12.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.993
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 32 12
2021/20221.113 5 3 0 6 4 31 5 38 176 79 210 556
2022/20231.574 234 86 24 135 162 182 2 134 250 285 51 29
2023/2024923 34 156 216 36 31 58 19 81 9 16 164 103
2024/20255.840 328 381 13 94 142 257 554 325 503 597 2.084 562
2025/202611.160 1.209 589 1.025 1.138 2.085 590 1.428 611 1.381 776 328 0
Totale 22.660